Gemtesa

Gemtesa is a brand name for the prescription medication vibegron. It is used to treat adults with overactive bladder (OAB) who experience symptoms such as urinary urgency, frequency, and incontinence. Gemtesa works by relaxing the muscles in the bladder, which helps to increase bladder capacity and reduce the urge to urinate.

The active ingredient in Gemtesa is vibegron, a beta-3 adrenergic agonist. Beta-3 receptors are found in the bladder wall. When vibegron binds to these receptors, it stimulates the detrusor muscle to relax. This relaxation allows the bladder to hold more urine before the urge to void is felt.

Gemtesa is taken orally, typically as a 75 mg tablet once a day. It can be taken with or without food. It is important to take Gemtesa exactly as prescribed by a healthcare professional. Common side effects may include headache, nasopharyngitis (common cold symptoms), diarrhea, nausea, and urinary tract infection. Serious side effects are rare but can include increased blood pressure and hypersensitivity reactions.

Gemtesa is not recommended for individuals with severe uncontrolled hypertension or those with known hypersensitivity to vibegron. It is important to discuss any pre-existing medical conditions and other medications being taken with a doctor before starting Gemtesa. The effectiveness and safety of Gemtesa in pregnant or breastfeeding women have not been established.